Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Mucormycosis (formerly zygomycosis) is an uncommon but emerging infection that occurs in immunocompromised patients, including children and neonates. Previously, the term zygomycosis was used to refer to syndromes of mucormycosis and entomophthoromycosis, but updates in taxonomy determined that the phylum name Zygomycota is invalid. Because the phylum Zygomycota no longer exists, the term zygomycosis has become obsolete. , Molds causing these infections are now in the phyla Mucoromycota, Basidiobolomycota, and Entomophthoromycota, subphyla Mucoromycotina, Basidiobolomycotina, and Entomophthoromycotina, respectively. , Infectious agents in the orders Entomophthorales and Basidiobolales (e.g., the genera Conidiobolus and Basidiobolus ) produce distinct cutaneous and subcutaneous disease syndromes that are not discussed in this chapter. Because clinically significant genera are in the subphylum Mucoromycotina, order Mucorales, the term mucormycosis is a useful clinical and valid mycologic reference. , Organisms in this order are characterized by the formation of broad, aseptate, or rarely septate hyphae and by sexual reproduction with formation of zygospores. The Mucorales are divided into several families of significance in human or animal disease, although most cases of human infection are caused by members of the family Mucoraceae. These families have undergone taxonomic revisions based on molecular, physiologic, and phylogenetic studies, including the reclassification of the genus Absidia (in part) to the family Lichtheimiaceae for pathogenic species that are able to survive at temperatures of ≥37°C. The family Mucoraceae produces sporangiospores (asexual spores) in a closed, sac-like structure called a sporangium that are released when the wall ruptures. The sporangium is attached to the hyphal substratum with a stalk-like structure, the sporangiophore. Different species are distinguished by the microscopic appearance of the sporangiophores, sporangia, and sporangiospores, as well as by the presence or absence of rhizoids (root-like structures) that anchor sporangiophores to the substratum. In the family Mucoraceae, members of the genera Rhizopus, Mucor, Actinomucor, Rhizomucor, and Apophysomyces all have been implicated in human disease. Less frequently reported genera in human disease in other families include Cunninghamella, Saksenaea, Syncephalastrum, Cokeromyces, and Lichtheimia . ,
The species isolated from cases of human infection are ubiquitous in decomposing organic matter such as spoiled bread, fruit, and other food items, as well as in soil. The most commonly encountered human pathogen is Rhizopus arrhizus ( R. oryzae ) , but many other species have been implicated. , All these organisms cause similar syndromes in children and neonates. ,
Mucormycosis generally is acquired through inhalation of spores; the lungs and sinuses are the most common initial sites of infection. Less commonly, disease can arise after ingestion of contaminated foods or by direct inoculation following trauma or through vascular catheters, an important route of nosocomial transmission in neonates. , In an immunocompetent host, pulmonary macrophages ingest and kill inhaled sporangiospores. , In diabetic hosts and other immunosuppressed patients, macrophages fail to suppress spore germination. Once infection is established, neutrophils have a pivotal role in killing hyphae. Severe neutropenia increases the risk of invasive infection, as does ketoacidosis in diabetic patients because of abnormal neutrophil function.
The spores of Mucorales are ubiquitous in the environment, but they only rarely cause infection without predisposing host factors. Certain predisposing conditions are associated with specific clinical manifestations of disease. For example, patients who have diabetic ketoacidosis typically have rhinocerebral mucormycosis. In patients with leukemia and other causes of neutropenia who are receiving cytotoxic chemotherapy, rhinocerebral, pulmonary, or disseminated disease can develop. Infants and children with severe malnutrition can have gastrointestinal tract mucormycosis. , Patients receiving deferoxamine for iron overload states also are at increased risk for mucormycosis. ,
Prolonged neutropenia is well recognized as an important risk factor for mucormycosis among patients with leukemia and recipients of bone marrow or hematopoietic stem cell transplants. Other contributing factors in these patients are the use of corticosteroids and broad-spectrum antibacterial agents. , , , Prolonged use of antifungal agents without activity against Mucorales (especially voriconazole, but also the echinocandins and fluconazole) in severely immunosuppressed patients has been reported as a risk factor for mucormycosis.
In children, mucormycosis often develops in settings similar to those seen in adults, including neutropenia, solid-organ transplantation, hematopoietic stem cell or bone marrow transplantation, burns, and deferoxamine treatment for management of iron overload. , Infection occurs in distinct settings in children and neonates as well. These conditions include diabetes mellitus in children, particularly with uncontrolled diabetic ketoacidosis, and cutaneous infection in neonates. ,
Nosocomial outbreaks of mucormycosis have been linked to construction work, as well as to contaminated air conditioning systems. Nosocomial clusters of cutaneous infections, especially in neonates, have been traced to the use of contaminated biomedical devices (e.g., wooden tongue depressors) or have been associated with various adhesive bandages used in the hospital setting (e.g., elastic bandages or tape) and hospital linens. , However, because most cases of mucormycosis in hospitalized patients are sporadic, determining the site of inoculation or source of infection is difficult. ,
Mucormycosis has several clinical presentations. Rhinocerebral and pulmonary infections are by far the most common. Other common clinical manifestations are gastrointestinal, cutaneous, and disseminated infection, which can include central nervous system involvement. Similar to other angioinvasive molds, a characteristic feature of mucormycosis is vascular invasion, which results in thrombosis, infarction, and necrosis of surrounding tissue. Mucormycosis often is characterized by the rapid onset of a necrotic lesion, followed by a fulminant course that requires rapid and aggressive medical and surgical therapy.
Rhinocerebral mucormycosis often begins as a necrotic lesion in the paranasal sinuses, then infection spreads to involve the orbit, face, palate, and brain. The disease classically occurs in patients with diabetic ketoacidosis, but it also can occur in patients with neutropenia and other immunocompromising conditions. Most commonly, rhinocerebral mucormycosis progresses rapidly and requires extensive surgical debridement combined with antifungal therapy.
Initial symptoms can include nasal or sinus congestion or pain or epistaxis, along with fever. Black, necrotic lesions on the nasal or palatine mucosa are characteristic diagnostic signs, but the diagnosis often is not established early in infection. Infection can spread into the orbits and the periorbital or perinasal tissues and is associated with induration, necrosis, and edema. Ptosis, proptosis, dilation and fixation of the pupil, and loss of vision can occur. Infection can spread into the cavernous sinus and brain, with resulting abscess formation and necrosis of the frontal lobes.
Studies using computed tomography or magnetic resonance imaging are needed to assess the anatomic extent of suspected infection. The results of cerebrospinal fluid examination are nonspecific and do not assist in diagnosis.
Pulmonary mucormycosis is most common in severely neutropenic and other severely immunocompromised children, including children undergoing bone marrow or hematopoietic stem cell transplantation, particularly in the setting of graft-versus-host disease. , , , The clinical presentation usually is nonspecific and is similar to that of pneumonia caused by other angioinvasive molds ( Aspergillus ), and can include pleuritic chest pain, cough, fever, and hemoptysis. The radiologic signs also can be nonspecific but include nodular lesions, cavitation, and a reversed halo sign which is characterized by a nodule with a central ground-glass attenuation encircled by a ring of denser consolidation that can be used to distinguish pulmonary mucormycosis radiologically from invasive pulmonary aspergillosis. The mortality rate is high because of the unsuspected diagnosis in many patients, as well as the persistence of the underlying severe immunosuppression that predisposed the patient to infection.
Mucormycosis of the gastrointestinal tract is rare but occurs in malnourished infants and children. In one review, 19 of 34 children with this gastrointestinal mucormycosis were <1 year of age. , All segments of the gastrointestinal tract can be involved, but the most commonly affected sites are the stomach, large and small intestine, and esophagus.
Symptoms reflect the site affected but are not specific and include abdominal pain and hematemesis or gastrointestinal tract bleeding. Gastrointestinal mucormycosis can be complicated by perforation, perirenal abscess, and renal infarction. The course of the disease can be rapid, and survival is rare because of the severely immunocompromised state of the host and the difficulty in making the diagnosis.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here